经导管主动脉瓣置换术后使用质胺的安全性和有效性。

IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Indian heart journal Pub Date : 2024-09-01 DOI:10.1016/j.ihj.2024.09.001
Lakshmi Durga Kumaraguruparan , Asuwin Anandaram , Kamalakkannan G. Sambandam , Yogapriya Chidambaram , Bharath Raj Kidambi , Gautam Ganesan Karthikeyan , Madhesh Kasi , Rizwan Suliankatchi Abdulkader , Sankaran Ramesh , Vadivelu Ramalingam , Ravindran Rajendran , Nagendra Boopathy Senguttuvan
{"title":"经导管主动脉瓣置换术后使用质胺的安全性和有效性。","authors":"Lakshmi Durga Kumaraguruparan ,&nbsp;Asuwin Anandaram ,&nbsp;Kamalakkannan G. Sambandam ,&nbsp;Yogapriya Chidambaram ,&nbsp;Bharath Raj Kidambi ,&nbsp;Gautam Ganesan Karthikeyan ,&nbsp;Madhesh Kasi ,&nbsp;Rizwan Suliankatchi Abdulkader ,&nbsp;Sankaran Ramesh ,&nbsp;Vadivelu Ramalingam ,&nbsp;Ravindran Rajendran ,&nbsp;Nagendra Boopathy Senguttuvan","doi":"10.1016/j.ihj.2024.09.001","DOIUrl":null,"url":null,"abstract":"<div><div>Transfemoral Trans-catheter Aortic Valve Replacement (TF-TAVR) is a safe alternative to surgical aortic valve replacement (SAVR). Protamine is used to reverse heparin and reduce post-TAVR bleeding, but concerns about risks like valve thrombosis and stroke remain. This systematic review and meta-analysis, following PRISMA guidelines, found no statistically significant difference in major bleeding complications between the protamine and control groups [(3.0 % vs. 14.4 %); RR: 0.56; P = 0.16]. No differences were noted in life-threatening bleeding, blood transfusions, 30-day mortality, or stroke. Protamine appears safe post-TAVR without increasing stroke risk, but its effectiveness in reducing bleeding needs further investigation through a multicentric randomized study.</div></div>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":"76 5","pages":"Pages 352-354"},"PeriodicalIF":1.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety and efficacy of protamine after transcatheter aortic valve replacement\",\"authors\":\"Lakshmi Durga Kumaraguruparan ,&nbsp;Asuwin Anandaram ,&nbsp;Kamalakkannan G. Sambandam ,&nbsp;Yogapriya Chidambaram ,&nbsp;Bharath Raj Kidambi ,&nbsp;Gautam Ganesan Karthikeyan ,&nbsp;Madhesh Kasi ,&nbsp;Rizwan Suliankatchi Abdulkader ,&nbsp;Sankaran Ramesh ,&nbsp;Vadivelu Ramalingam ,&nbsp;Ravindran Rajendran ,&nbsp;Nagendra Boopathy Senguttuvan\",\"doi\":\"10.1016/j.ihj.2024.09.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Transfemoral Trans-catheter Aortic Valve Replacement (TF-TAVR) is a safe alternative to surgical aortic valve replacement (SAVR). Protamine is used to reverse heparin and reduce post-TAVR bleeding, but concerns about risks like valve thrombosis and stroke remain. This systematic review and meta-analysis, following PRISMA guidelines, found no statistically significant difference in major bleeding complications between the protamine and control groups [(3.0 % vs. 14.4 %); RR: 0.56; P = 0.16]. No differences were noted in life-threatening bleeding, blood transfusions, 30-day mortality, or stroke. Protamine appears safe post-TAVR without increasing stroke risk, but its effectiveness in reducing bleeding needs further investigation through a multicentric randomized study.</div></div>\",\"PeriodicalId\":13384,\"journal\":{\"name\":\"Indian heart journal\",\"volume\":\"76 5\",\"pages\":\"Pages 352-354\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian heart journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0019483224001810\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian heart journal","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0019483224001810","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

经口经导管主动脉瓣置换术(TF-TAVR)是外科主动脉瓣置换术(SAVR)的安全替代方案。原胺用于逆转肝素并减少TAVR术后出血,但对瓣膜血栓和中风等风险的担忧依然存在。这项系统回顾和荟萃分析遵循了 PRISMA 指南,发现在大出血并发症方面,丙胺组和对照组之间没有统计学意义上的显著差异[(3.0 % vs. 14.4 %);RR:0.56;P = 0.16]。在危及生命的出血、输血、30 天死亡率或中风方面没有差异。TAVR术后使用普罗胺似乎是安全的,不会增加中风风险,但其减少出血的效果还需要通过多中心随机研究进行进一步调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Safety and efficacy of protamine after transcatheter aortic valve replacement
Transfemoral Trans-catheter Aortic Valve Replacement (TF-TAVR) is a safe alternative to surgical aortic valve replacement (SAVR). Protamine is used to reverse heparin and reduce post-TAVR bleeding, but concerns about risks like valve thrombosis and stroke remain. This systematic review and meta-analysis, following PRISMA guidelines, found no statistically significant difference in major bleeding complications between the protamine and control groups [(3.0 % vs. 14.4 %); RR: 0.56; P = 0.16]. No differences were noted in life-threatening bleeding, blood transfusions, 30-day mortality, or stroke. Protamine appears safe post-TAVR without increasing stroke risk, but its effectiveness in reducing bleeding needs further investigation through a multicentric randomized study.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Indian heart journal
Indian heart journal CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.60
自引率
6.70%
发文量
82
审稿时长
52 days
期刊介绍: Indian Heart Journal (IHJ) is the official peer-reviewed open access journal of Cardiological Society of India and accepts articles for publication from across the globe. The journal aims to promote high quality research and serve as a platform for dissemination of scientific information in cardiology with particular focus on South Asia. The journal aims to publish cutting edge research in the field of clinical as well as non-clinical cardiology - including cardiovascular medicine and surgery. Some of the topics covered are Heart Failure, Coronary Artery Disease, Hypertension, Interventional Cardiology, Cardiac Surgery, Valvular Heart Disease, Pulmonary Hypertension and Infective Endocarditis. IHJ open access invites original research articles, research briefs, perspective, case reports, case vignette, cardiovascular images, cardiovascular graphics, research letters, correspondence, reader forum, and interesting photographs, for publication. IHJ open access also publishes theme-based special issues and abstracts of papers presented at the annual conference of the Cardiological Society of India.
期刊最新文献
Attainment of low-density lipoprotein cholesterol goals in patients undergoing coronary revascularization in the contemporary clinical practice. Psychological problems and burnout among healthcare workers: impact of non-pharmacological lifestyle interventions. Community-level knowledge, attitudes, and practices regarding cardiovascular diseases and modifiable risk factors in India. Morphological characterization of coronary plaques in young indian patients with acute coronary syndrome: A multicentric study. Long-term outcomes of percutaneous coronary intervention in patients with prior coronary artery bypass graft - A retrospective experience
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1